1) invasive cribriform carcinoma
浸润性筛状癌
1.
Clinicopathology and immunophenotype of invasive cribriform carcinoma of the breast;
乳腺浸润性筛状癌的临床病理及免疫表型
2.
Purpose To study the clinicopathological and immunohistochemical characteristics of invasive cribriform carcinoma (ICC) of the breast.
目的探讨乳腺浸润性筛状癌(invasivecribriformcarcinoma,ICC)的临床病理和免疫表型特点。
2) invasive micropapillary carcinoma
浸润性微乳头状癌
1.
A case report of invasive micropapillary carcinoma of the breast and literature review;
乳腺浸润性微乳头状癌1例及文献复习
2.
Clinicopathological study of invasive micropapillary carcinoma of the breast:A report of 14 cases;
乳腺浸润性微乳头状癌临床病理学研究(附14例报道)
3.
Objective: To investigate the relationship between the clinicopathologic characteristics of invasive micropapillary carcinoma of breast (IMPC) and the prognosis.
目的:研究浸润性微乳头状癌的临床病理特征及其与预后间的关系。
3) IMPC
乳腺浸润性微乳头状癌
1.
ObjectiveStudy the expression of Fez1/Lzts1 protein and the association with clinicopathologic feature in invasive micropapillary carcinoma of the breast(IMPC).
【目的】研究FEZ1/LZTS1基因在乳腺浸润性微乳头状癌(IMPC)中的表达,分析其与淋巴结转移等相关病理学特征的关系;并从表观遗传学角度探讨FEZ1/LZTS1基因启动子区域甲基化在IMPC浸润转移过程中的作用。
2.
Objective To study the stem cell phenotype of invasive micropapillary carcinoma(IMPC)of the breast.
目的研究乳腺浸润性微乳头状癌(invasive micropapillary carcinoma,I MPC)的干细胞表型,从干细胞和上皮间质转化(epithelial-mesenchymal transition,EMT)角度探讨I MPC高侵袭、高转移恶性生物学行为的原因。
4) infiltrating ductal carcinoma
浸润性导管癌
1.
Differential proteomic analysis in stage Ⅱ breast infiltrating ductal carcinoma tissue with negative estrogen receptor
ER~- Ⅱ期乳腺浸润性导管癌的差异表达蛋白质分析
2.
Objective:The aim of this study was to investigate the X-ray features of infiltrating ductal carcinoma and to analysis its pathological basis and to rise the level of the preoperative diagnostic accuracy.
目的:研究浸润性导管癌的X线表现,分析其病理学基础,以提高乳腺癌手术前的诊断水平。
3.
Purpose To detect the expression of matrix metalloproteinase-26(MMP-26) in human benign and malignant breast tissues,to evaluate the relationship of MMP-26 expression in infiltrating ductal carcinoma(IDC)with clinicopathological parameters and its potential value in tumor progression and to explore the correlation of MMP-26 with estrogen receptor(ER).
方法应用免疫组化SP法,检测MMP-26蛋白在正常乳腺组织、乳腺增生症、原位癌和乳腺浸润性导管癌(IDC)中的表达,以及ER在IDC中的表达并进行评分,结果用INSTAT统计软件分析。
5) Invasive ductal carcinoma
浸润性导管癌
1.
Expression of Ezrin and Galectin-3 and their clinicopathological significance in breast invasive ductal carcinoma;
乳腺浸润性导管癌中Ezrin、Galectin-3的表达及临床病理意义
2.
Reproducibility in evaluating immunohistochemical results of HER2 expression in breast invasive ductal carcinoma;
乳腺浸润性导管癌HER2免疫组化检测结果判定的重复性研究
3.
Expression and clinicopathologic significance of Ki-67 in breast invasive ductal carcinoma;
乳腺浸润性导管癌Ki-67表达及其临床病理学意义
6) Mammary invasive carcinoma
乳腺浸润性癌
补充资料：膀胱浸润性癌
膀胱浸润性癌
infiltrating carcinoma of bladder
又称“实体性癌”。恶性度高，无乳头，表面不平，有显著坏死及钙盐沉着，溃疡边缘呈结节状，早期向深处浸润，转移较早。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条